analyst
AA
NASDAQ · AARD
Aardvark Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$1.36
Down-$0.08 (-5.56%)
Updated Oct 31, 2026, 1:36 PM
SID Score
2.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 271.95M
- P/E ratio
- -5.56
- Dividend yield
- 0.00%
- 52-week range
- $0.93 – $16.60
- Volume
- 467.6K
- Avg. volume
- 188.95K
Price performance · AARD
AARD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
AARD closed at $1.36 after 21 trading sessions, down 72.75% for the selected period.
- Last close
- $1.36
- Period change
- -72.75%
- Period low
- $1.08
- Period high
- $5.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $1.39 | $1.46 | $1.33 | $1.36 | 467.6K |
| Oct 29, 2026 | $1.48 | $1.53 | $1.3618 | $1.44 | 955.89K |
| Oct 28, 2026 | $1.22 | $1.59 | $1.1756 | $1.51 | 2.03M |
| Oct 27, 2026 | $1.09 | $1.39 | $1.09 | $1.30 | 4.28M |
| Oct 26, 2026 | $1.245 | $1.39 | $0.93 | $1.08 | 4.96M |
| Oct 23, 2026 | $2.99 | $3.00 | $1.39 | $1.39 | 16.35M |
| Oct 22, 2026 | $4.27 | $4.31 | $3.89 | $3.95 | 1.42M |
| Oct 21, 2026 | $3.95 | $4.54 | $3.95 | $4.41 | 218.46K |
| Oct 20, 2026 | $3.80 | $4.0514 | $3.78 | $3.90 | 66.7K |
| Oct 19, 2026 | $3.75 | $4.05 | $3.64 | $3.74 | 135.28K |
| Oct 16, 2026 | $4.19 | $4.19 | $3.73 | $3.78 | 97.17K |
| Oct 15, 2026 | $3.86 | $3.977 | $3.77 | $3.86 | 68.8K |
| Oct 14, 2026 | $3.93 | $4.35 | $3.83 | $3.88 | 126.57K |
| Oct 13, 2026 | $4.44 | $4.63 | $4.03 | $4.04 | 218.3K |
| Oct 12, 2026 | $4.81 | $4.8771 | $4.40 | $4.45 | 99.87K |
| Oct 9, 2026 | $4.61 | $4.82 | $4.60 | $4.76 | 140.86K |
| Oct 8, 2026 | $4.77 | $5.09 | $4.57 | $4.71 | 315.97K |
| Oct 7, 2026 | $4.95 | $5.33 | $4.69 | $4.96 | 212.13K |
| Oct 6, 2026 | $5.28 | $5.45 | $4.66 | $5.04 | 251.86K |
| Oct 5, 2026 | $5.03 | $5.37 | $5.03 | $5.22 | 62.25K |
| Oct 2, 2026 | $5.37 | $5.66 | $4.88 | $4.99 | 147.7K |
Latest AARD news
The latest Smart Investors Daily articles mentioning AARD.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…